miR-21 predicts poor prognosis in patients with osteosarcoma

References

• Kansara M, Teng MW, Smyth MJ, et al. Translational biology of osteosarcoma. Nat. Rev. Cancer. 2014;14:722–735.10.1038/nrc3838
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr. Opin. Oncol. 2013;25:398–406.10.1097/CCO.0b013e3283622c1b
   PubMed Web of Science ®Google Scholar
• Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2010;152:3–13.10.1007/978-1-4419-0284-9
   Google Scholar
• Duong LM, Richardson LC. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999–2008. J. Registry Manag. 2013;40:59–64.
   PubMedGoogle Scholar
• Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat. Rev. Genet. 2013;14:535–548.10.1038/nrg3471
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 2012;13:358–369.10.1038/nrg3198
   PubMed Web of Science ®Google Scholar
• Lian D, Wang ZZ, Liu NS. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. Eur. Rev. Med. Pharmacol. Sci. 2016;20:1258–1262.
   PubMed Web of Science ®Google Scholar
• Taheriazam A, Talaei AJ, Jamshidi M, et al. Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma. Diagn. Pathol. 2015;10:184.10.1186/s13000-015-0422-x
   PubMed Web of Science ®Google Scholar
• Wang T, Ji F, Dai Z, et al. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma. Cancer Biomark. 2015;15:543–550.10.3233/CBM-150493
   PubMed Web of Science ®Google Scholar
• Mirghasemi A, Taheriazam A, Karbasy SH, et al. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int. 2015;15:86.10.1186/s12935-015-0237-6
   PubMed Web of Science ®Google Scholar
• Liu W, Zhao ZY, Shi L, et al. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Diagn. Pathol. 2015;10:116.10.1186/s13000-015-0329-6
   PubMed Web of Science ®Google Scholar
• Tang J, Zhao H, Cai H, et al. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma. Biomed. Pharmacother. 2015 Apr;71:222–226.10.1016/j.biopha.2015.01.025
   PubMed Web of Science ®Google Scholar
• Wang G, Shen N, Cheng L, et al. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma. Tumour Biol. 2015;36:7891–7895.10.1007/s13277-015-3379-1
   PubMed Web of Science ®Google Scholar
• Wang ZX, Bian HB, Wang JR, et al. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J. Surg. Oncol. 2011;104:847–851.10.1002/jso.22008
   PubMed Web of Science ®Google Scholar
• Winther M, Alsner J, Tramm T, et al. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer. Acta Oncol. 2015;54:1582–1591.10.3109/0284186X.2015.1064161
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhou X, Ji J, et al. High expression levels of miR-21 and miR-210 predict unfavorable survival in breastcancer: a systemic review and meta-analysis. Int. J. Biol. Markers. 2015;30:e347–e358.
   PubMed Web of Science ®Google Scholar
• Sondermann A, Andreghetto FM, Moulatlet AC, et al. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Clin. Exp. Metastasis. 2015;32:521–530.10.1007/s10585-015-9724-3
   PubMed Web of Science ®Google Scholar
• Menéndez P, Padilla D, Villarejo P, et al. Prognostic implications of serum microRNA-21 in colorectal cancer. J. Surg. Oncol. 2013;108:369–373.10.1002/jso.23415
   PubMed Web of Science ®Google Scholar
• Ziyan W, Shuhua Y, Xiufang W, et al. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med. Oncol. 2011;28:1469–1474.10.1007/s12032-010-9563-7
   PubMed Web of Science ®Google Scholar
• Lv C, Hao Y, Tu G. MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in humanosteosarcoma line MG63 through PTEN/Akt pathway. Tumour Biol. 2016;16:23–28.
   Google Scholar
• Manne U, Srivastava RG, Srivastava S. Keynote review: recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov. Today. 2005;10:965–976.10.1016/S1359-6446(05)03487-2
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001;69:89–95.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 2008;358:1919–1928.10.1056/NEJMoa074256
   PubMed Web of Science ®Google Scholar
• Zhu DX, Zhu W, Fang C, et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis. 2012;33:1294–1301.10.1093/carcin/bgs179
   PubMed Web of Science ®Google Scholar
• Qiu S, Lin S, Hu D, et al. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J. Trans. Med. 2013;11:10.10.1186/1479-5876-11-10
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Li Y, et al. Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization. PLoS ONE. 2013;8:e53582.10.1371/journal.pone.0053582
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189–198.10.1016/j.ccr.2006.01.025
   PubMed Web of Science ®Google Scholar
• Volinia S. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Nat. Acad. Sci. USA. 2006;103:2257–2261.10.1073/pnas.0510565103
   PubMed Web of Science ®Google Scholar
• Lee JA, Lee HY, Lee ES, et al. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J. Breast Cancer. 2011;14:269–275.10.4048/jbc.2011.14.4.269
   PubMed Web of Science ®Google Scholar
• Quesne JL, Jones J, Warren J, et al. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. J. Pathol. 2012;227:306–314.10.1002/path.3983
   PubMed Web of Science ®Google Scholar